Cytarabine is an antimetabolite chemotherapy agent primarily used in the treatment of certain leukemias, such as acute myeloid leukemia (AML), and lymphomas. It works by inhibiting DNA synthesis in rapidly dividing cancer cells, ultimately leading to cell death. Due to its critical therapeutic role and narrow safety margin, maintaining the pharmaceutical purity of Cytarabine is essential for patient safety and treatment effectiveness. Impurity profiling is vital to detect and control degradation products and synthesis-related impurities that may impact the drug's quality. Here are some of its known impurities listed below.
Showing 1 - 1 of 1 products
Catalogue No : CYTR-OCL-001
CAS No : 58-96-8
In Stock
Synonyms
Uridine 1-ß-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione
Uridine 1-ß-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione